Figure 2From: Long-term Safety and Efficacy of Human-Induced Pluripotent Stem Cell (iPS) Grafts in a Preclinical Model of Retinitis PigmentosaExpression of pluripotency markers in human iPS cells at d 14. Left column: DAPI stained nuclei. Middle column: cells labeled with TRA-1-60, SSEA4, NANOG or SOX2 antibodies; markers of pluripotency. Right column: merged images. Scale bar, 50 µm.Back to article page